The global Drug Discovery Informatics Market size is expected to reach USD 2.07 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 12.6% during the forecast period. Drug therapy is evolving in response to health care needs of the population. The most recent trend is to develop drugs for treatment of chronic diseases, especially those affecting the older population.
Cardiovascular
Diseases (CVDs), stroke, and cancer are the most prevalent health issues and
also the most common conditions causing death. Moreover, treatment expenses and
costs pertaining to these diseases are very high, which triggers the demand for
effective novel molecules. In the U.S. alone, revenue generated through CVD
treatments was over USD 444 billion in 2010, and it has been estimated to claim
more lives each year than the remaining causes of death combined.
Clinical
decision support tools, which include online database for assistance in
enhancement of clinical decisions, are timely updated and that significantly
impacts market growth. Moreover, the World Health Organization's Consultative
Expert Working Group for Research and Development is also involved in
evaluation and development of open source drug discovery platforms.
Introduction of open drug discovery tool kit (ODDT), which serves as a tool for
computer-aided drug discovery by implementing machine learning scoring
functions (RF-Score and NN-Score), is anticipated to work in favor of the
market.
Request
a sample copy or view summary of this report@ https://www.grandviewresearch.com/industry-analysis/drug-discovery-informatics-market
Further key findings from the report suggest:
- Lead
generation and lead optimization are anticipated to witness hand-in-hand
growth owing to usage of similar IT solutions
- Presence of
different co-operation models, such as joint ventures, strategic
partnership, price competition, and project selection, for outsourcing
drug informatics solutions in the industry is influencing the growth of
the market positively
- North
America is projected to hold prominent position in the arena throughout
the forecast period. Higher incidence rates of different infectious
diseases and oncology diseases are expected to drive the demand for
informatics solutions to aid drug discovery and development. Presence of
molecular R&D laboratories and market players in the U.S. is
supplementing the growth of the regional market
- Asia Pacific
is likely to post the highest CAGR during the same period, owing to cost
saving advantage offered by the region
- Some of the
key players operating in the market Boehringer Ingelheim GmBh; ChemAxon;
Jubilant Biosys; Certara; Selvita; Novo Informatics; Albany Molecular
Research Inc.; Infosys; DiscoverX; Collaborative Drug Discovery Inc; GVK
Biosciences; and Charles River Laboratories.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment